Organigram Global Inc. · TSX:OGI
Organigram Global — Investor Presentation (July 2019)
28 slides from Organigram Global's investor presentation, Jul 14, 2019
Slide 1: Investor Presentation
Investor Presentation NASDAQ (OGI) TSX Venture (OGI)
Slide 2: Cautionary Statement
Cautionary Statement This document is current as of July 14, 2019, except where otherwise stated. The information contained in this presentation is provided by Organigram ("OGI" or the “Company") for informational purposes only and does not constitute an offer to issue or arrange to issue, or the so
Slide 3: Organigram at a Glance
* Leading licensed producer (LP) of premium quality product for Medical & Adult Recreational Markets * Market cap of ~$1.2 Billion Organigram ata * Expanding indoor, unique three-level production Glance facility in Moncton NB * Sales to all 10 provinces * Expanding global footprint with internationa
Slide 4: Investment Thesis
Investment Thesis ¥ Low cost of cultivation’, debunking claims indoor high quality production = high cost v Increasing target production capacity to 113,000 kg/yr* construction expected to be completed in December 2019 v One of only four Canadian LPs with distribution agreements in all 10 provinces
Slide 5: Q3 2019 Highlights
• Q3 net revenue from: • Q3 adjusted gross margin impacted by • Q3 marks fourth quarter in a row of higher production costs, temporary • 3,926 kg of dried flower and 5,090 positive adjusted EBITDA decline in yields and write-offs of legacy L of oil sold packaging • Q3 SG&A3 at 37% of net revenue • $
Slide 6: Maximize footprint
Maximizé footprint Critical facets of environme controlled
Slide 7: Phase Expansion on Schedule
Phase 4 Expansion on Schedule 113,000 KG/YR TARGET PRODUCTION CAPACITY » With Phase 4A completed, current licensed 24,000 KG/YR production capacity is 61,000kg/yr’ UNDER 89,000 KG/YR CONSTRUCTION Entire Phase 4 expected to be completed in December 2019 for total target production capacity of 113,000
Slide 8: Phase 5 Refurbishment for Edibles and Derivative Products
Phase 5 - Refurbishment for Edibles and Derivative Products * 56,000 square feet within existing Moncton Campus facility being refurbished and designed under EU GMP standards for: * An edibles and derivative production facility; and g z fa Fa g 2 Fa * Additional extraction capacity * Primary constru
Slide 9: Well-positioned for Edibles and Derivatives
Well-positioned for Edibles and Derivatives THE (GREEN) Valeo werk SOLUTION ° Exclusive agreement with The Green Immediate increased extraction Solution, a proven market leader in capacity from Valens GroWorks the US for consulting services re: product agreement and Phase 5 jerocessing and developme
Slide 10: Cowen THC Tracker: U.S. Brands
10 1 QUICK TAKE - Cannabis - Cowen's THC Tracker: U.S. Brands - Cowen and Company, March 29, 2019
Slide 11: Innovative Vaporizer Experiences
Innovative Vaporizer Experiences * Selected as one of only four Canadian partners of PAX Era, the premium oil vaporizer created by PAX Labs, Inc. » Pax Labs, Inc. - a leader in the design and development of premium app-controlled vape technologies for cannabis » Plans to offer Edison Cannabis Co. br
Slide 12: Investment in Innovative Chocolate
Investment in Innovative Chocolate production line » $15 million investment commitment in a high-speed, high-capacity, fully-automated production line with capacity of up to 4 million kg of chocolate cannabis edibles per year * OGI product development and production team with more than 25 years of c
Slide 13: Proprietary Nano-Emulsification Technology
Proprietary Nano-Emulsification Technology * Planning to launch dried powder formulation beverage products in early calendar 2020 in Canada * Proprietary nano-emulsion technology, developed based on analytical testing, used to create products with an initial onset of 10-15 minutes * Shelf-stable, th
Slide 14: Investment in Disruptive Technology - Biosynthesis
Investment in Disruptive Technology- Biosynthesis * Investment in Hyasynth, a biotech company and leader in the field of cannaboid science and biosynthesis 4 » Hyasynth developed a disruptive technology - biosynthesis - to naturally produce cannabinoids without growing cannabis plant + Process has t
Slide 15: International Markets
International Markets alpha-cannabis C Pharma GmbH * Alpha-cannabis®, a German company strategically positioned to serve the German medical market * Strong networking ties and knowledge in the German scientific and regulatory environment As Partners we see the following collaboration possibilities:
Slide 16: Seizing the Significant Hemp-CBD Opportunity
Seizing the Significant Hemp-CBD Opportunity Global CBD * CBD increasingly being used in a number of health and wellness Market products worldwide » Agreement with 1812 Hemp, an industrial hemp research company, to secure supply and support R&D on the genetic improvement of hemp to maximize yields a
Slide 17: Pre-rolls 7% & other
• • • • Pre-rolls • 7% & other • • • 17
Slide 18: Canadian, US and International Markets
CANADIAN, US and INTERNATIONAL MARKETS • • • • • • • 18
Slide 19: Appendix
Appendix
Slide 20: Q3 2019 and YTD Fiscal 2019 Metrics
Q3 2019 and YTD Fiscal 2019 Metrics C$M unless otherwise indicated Q3 and YTD for 9 Months Ended May 31, 2019 Q3 YTD Q3 and 2018 Fiscal Year-End Q3 Aug 31, 2018 Net Revenue 24.8 64.1 Cash & Short Term Investments 87.8 130.0 Cost of Sales and Indirect Production 12.5 27.0 Inventories 94.2 45.0 Adjust
Slide 21: Experienced Management Team
Experienced Management Team Gregory Engel Chief Executive Officer En iGaeen e Sr. Vice President Marketing &Communications Tim Emberg Sr. Vice President of Sales and Commercial Operations * Previous Senior Director of Sales and Marketing for Moosehead Breweries Ltd * 15 years of experience in the ma
Slide 22: Adult Recreational Brand Portfolio
Adult Recreational Brand Portfolio a, Mm oti Pricing Segment © Valu Premium Pre Ultra Premium Available Formats * ' Pre. Pre-Roll and Oil Tangible Brand Attributes
Slide 23: 23
23 23
Slide 24: Phase 4B Fit Up
Phase 4B Fit Up
Slide 25: Phase 4C Steel Being Erected
Phase 4C Steel Being Erected
Slide 26: 26 26
26 26
Slide 27: Fully Automated Labeling
Fully Automated/Lakeling Raith and Excise Stam P APR cam
Slide 28: Fully Automated Packing Line
Fully Automated Packing Line
Organigram Global — Investor Presentation (July 2019) on 6ix